Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation of initial Phase 1 data ...

Crinetics Pharmaceuticals announces data presentations at ENDO 2025, highlighting PALSONIFY™ for acromegaly and atumelnant for CAH.

No additional treatment- or therapy-related deaths or Grade ≥3 cytokine release syndrome (CRS) or ICANS events have occurred since the previous data presentation in December 2024. Conclusions ...

Inflammatory bowel disease (IBD) is a chronic condition with significant health implications worldwide. In Nigeria, data on its prevalence and characteristics are limited, highlighting the need for ...

Nicole Gill of Cozen O'Connor discusses evidentiary hurdles and other challenges in presenting unconventional data in court and ways to overcome them.

Bicara Therapeutics announces interim results from a trial of ficerafusp alfa for head and neck cancer, highlighting promising efficacy.

To monitor progress in digital development and support the formulation of evidence-based strategies and action plans, ESCWA ...

Despite being based on the same dataset, they drew opposite conclusions about whether using a particular piece of kit during appendix-removal surgery reduced or increased the chances of infection.